SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis.

Data de publicació: 01/02/2022 Data Ahead of Print: 11/10/2021

Autors de IIS La Fe

Antonio Conde Moreno

Autor

Autors aliens a IIS La Fe

Lopez-Campos, F.
Cacicedo, J.
Couñago F
Garcia, R.
Leaman-Alcibar, O.
Navarro-Martin, A.
Perez-Montero, H.

Grups d'Investigació

Investigación Clínica y Traslacional en Cáncer

Leader

José Gómez Codina

Abstract

The use of stereotactic body radiation therapy (SBRT) to treat non-spine bone metastases (NSBM) is becoming increasingly common in clinical practice. The clinical advantages of SBRT include good pain control and high local control rates, although only limited data are available. The Spanish Society of Radiation Oncology (SEOR) SBRT group recently convened a task force of experts in the field to address key questions related to SBRT for NSBM, including treatment indications, planning, techniques, and dose fractionation. The task force reviewed the available literature to develop evidence-based recommendations for the safe application of NSBM SBRT and to standardize and optimize SBRT processes. The present document provides a comprehensive analysis of the available data, including ongoing clinical trials and controversies, providing clinically applicable recommendations.

Dades de la publicació

ISSN/ISSNe:: 1699-048X, 1699-3055
Tipus:: Article
Pàgines:: 215-226
DOI:: 10.1007/s12094-021-02695-6
PubMed:: 34633602
Factor d'Impacte:: 0,764 SCImago ℠
Quartil:: Q2 SCImago ℠

Documents

No hi ha documents

Mètriques

Filiacions

Lopez-Campos, F.:: Radiation Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Radiation Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Cacicedo, J.:: Radiation Oncology Department, Osakidetza/Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, Barakaldo, Spain

Department of Surgery, Radiology and Physical Medicine of the University of the Basque Country (UPV/EHU), Vizcaya, Spain

Radiation Oncology Department, Osakidetza/Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, Barakaldo, Spain

Department of Surgery, Radiology and Physical Medicine of the University of the Basque Country (UPV/EHU), Vizcaya, Spain
Couñago F:: Radiation Oncology Department, Hospital Universitario Quirón Salud, Hospital La Luz, Madrid, Universidad Europea de Madrid (UEM), Madrid, Spain

Radiation Oncology Department, Hospital Universitario Quirón Salud, Hospital La Luz, Madrid, Universidad Europea de Madrid (UEM), Madrid, Spain
Garcia, R.:: Radiation Oncology Department, Hospital Ruber Internacional Madrid, Madrid, Spain

Radiation Oncology Department, Hospital Ruber Internacional Madrid, Madrid, Spain
Leaman-Alcibar, O.:: Radiation Oncology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Radiation Oncology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain
Navarro-Martin, A.:: Radiation Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain

Radiation Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
Perez-Montero, H.:: Radiation Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain

Radiation Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
Conde-Moreno, A.:: Radiation Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, CEU Cardenal Herrera University, Castellón, Spain

Radiation Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, CEU Cardenal Herrera University, Castellón, Spain